humor

(CRHoy.com) 6.3% of minors 6 months to 5 years they already have the 3 doses of the vaccine against COVID-19 and with this they completed the vaccination scheme against that virus.

In this way it is evident in the Integrated Vaccine System (SIVA) of the Costa Rican Social Security Fund (CCSS) to the cutoff of the previous February 6.

The specialists of the Fund remember that, in this age group, the second vaccine is given 21 days after the first; and the third is applied 2 months after the second.

“Parents and guardians are invited to be aware of the vaccination dates of the three-dose scheme, to provide timely protection for infants. The institution still has doses available for this population, Therefore, parents are reminded of the importance of approaching vaccinations and thus protect their children”, commented Leandra Abarca, from the Epidemiological Surveillance sub-area.

The specialist recalled that three doses are required to have the complete scheme and that this vaccine is applied to the thigh to children from more than 6 months to less than 2 years and to children older than 2 years and children under 5 years of age are applied to the arm. Regarding the side effects, they explained that so far they have been mild, so there should be no concern for parents.

“It is of the utmost importance that the entire population is protected against this virus, to reduce the risk of hospitalizations and deaths due to COVID-19. Let’s remember that vaccines save lives,” added Diana Paniagua, from Epidemiological Surveillance.

In total, since the beginning of the vaccination campaign against this virus, the institution has already placed 12,860,149 doses. To find out about the authorized vaccination centers and the hours in which they work, you can click here with the official information of the institution.

(CRHoy.com) The National Commission for Vaccination and Epidemiology (CNVE) It analyzes extending the age for the indication to place the bivalent vaccine against COVID-19 that the country acquired.

“In upcoming sessions of the CNVE, the issue of the bivalent vaccine and its use in the age group of less than 12 years will be discussed; As soon as an agreement is reached in this regard, it will be communicated through official channels”, reported the CNVE through the institutional email before the consultation on the subject.

It should be remembered that last November, the technical committee agreed on the acquisition of this type of dose to use it as a reinforcement among those over 12 years of age, two months after the last vaccination received.

On January 19, the members of the decentralized collegiate body of the Ministry of Health, decided to advance the entry of these bivalent vaccines, this with the aim of having greater availability for those who want to apply the reinforcement against COVID-19.

“Therefore, the vaccines that would go in for the third and fourth trimesters will now go in for the first and second trimesters. In total, the country would have 507,400 vaccines for the first two quarters of this year,” the Ministry of Health detailed.

bivalent vaccines

Bivalent vaccines against SARS-COV-2 are those that contain two different types of antigens; one of the original COVID-19 strain that emerged in Wuhan, China; and another of the omicron BA variant.1., provocative of the most recent pandemic waves, along with its sublineages.

However, each note that the United States Food and Drug Administration (FDA) authorities explained that these do not replace the original doses in their previous first, second, third, and fourth dose placements. to the bivalent